BRIDGEWAY CAPITAL MANAGEMENT, LLC - AMNEAL PHARMACEUTICALS INC ownership

AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 140 filers reported holding AMNEAL PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.52 and the average weighting 0.1%.

Quarter-by-quarter ownership
BRIDGEWAY CAPITAL MANAGEMENT, LLC ownership history of AMNEAL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$444,000
+4.2%
83,2000.0%0.01%0.0%
Q2 2021$426,000
-33.7%
83,200
-13.0%
0.01%
-33.3%
Q1 2021$643,000
-50.2%
95,600
-66.1%
0.01%
-55.6%
Q4 2020$1,291,000
+26.1%
282,400
+7.0%
0.03%
+17.4%
Q3 2020$1,024,000
-12.4%
264,000
+7.5%
0.02%
-4.2%
Q2 2020$1,169,000245,5000.02%
Other shareholders
AMNEAL PHARMACEUTICALS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Fosun International Ltd 21,521,301$102,442,0009.84%
TPG Group Holdings (SBS) Advisors, Inc. 16,213,367$77,176,0001.36%
Sivik Global Healthcare LLC 600,000$2,856,0000.95%
THB ASSET MANAGEMENT 651,150$3,099,0000.90%
Eversept Partners, LP 886,587$4,220,1540.58%
Spark Investment Management LLC 30,100$143,0000.52%
GLOBEFLEX CAPITAL L P 240,680$1,146,0000.29%
Alambic Investment Management, L.P. 19,493$93,0000.23%
GSA CAPITAL PARTNERS LLP 49,901$238,0000.13%
C M BIDWELL & ASSOCIATES LTD 29,550$141,0000.13%
View complete list of AMNEAL PHARMACEUTICALS INC shareholders